Research.Patient.info

Anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) research hub

1 indexed studies · 0 currently recruiting

ongoing, recruitingTherapeutic confirmatory (Phase III)
Randomized, Multicenter, Phase III, Open-Label Study of Alectinib Versus Crizotinib In Treatment-Naive Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer
Poland · Spain · Portugal